Lyme Disease in Dogs: Symptoms, Diagnosis, Treatment, and Prevention Guide
This article is reviewed for clinical accuracy. Always consult your veterinarian for diagnosis and treatment.
Key Takeaways
- Lyme disease in dogs is caused by the spirochete bacterium Borrelia burgdorferi, transmitted through the bite of infected Ixodes ticks (primarily Ixodes scapularis, the black-legged or deer tick, in the eastern and midwestern United States, and Ixodes pacificus on the Pacific Coast); the tick must be attached for a minimum of 36 to 48 hours to transmit Borrelia, which means prompt, daily tick checks and removal within 24 to 36 hours after attachment can prevent infection in the vast majority of cases; other Borrelia genospecies (Borrelia garinii, Borrelia afzelii) cause Lyme disease in Europe but are clinically less important in dogs in North America.
- The clinical signs of Lyme disease in dogs differ substantially from those seen in humans: dogs do not develop the classic expanding bull’s-eye rash (erythema migrans) that is the hallmark of early human Lyme disease; instead, dogs typically present with acute-onset shifting-leg lameness (one or more limbs affected, often changing from limb to limb over days), fever (103 to 105 degrees Fahrenheit), peripheral lymphadenopathy (swollen lymph nodes near the affected joints), lethargy, and reduced appetite; these signs usually begin 2 to 5 months after tick exposure (not the 3 to 30 days typical in humans); the lameness in dogs is caused by Borrelia-induced inflammatory arthritis affecting the synovial membranes, rather than from direct joint infection.
- The most serious complication of Lyme disease in dogs is Lyme nephropathy (also called Lyme-associated protein-losing nephropathy), a severe immune-mediated glomerulonephritis (inflammation and damage to the glomerular filtration units of the kidneys) in which Borrelia antigen-antibody immune complexes deposit in the glomerular basement membrane, triggering complement activation and progressive renal injury; Lyme nephropathy is most commonly reported in Labrador Retrievers and Golden Retrievers and carries a very poor prognosis; clinical signs include proteinuria (protein in the urine, detected on urinalysis), progressive azotemia (elevated BUN and creatinine), hypoalbuminemia, peripheral edema or ascites, and rapidly progressive chronic kidney disease; screening for Lyme nephropathy with urine protein-to-creatinine ratio (UPC) is recommended for any Lyme-positive dog in these at-risk breeds.
- Diagnosis of Lyme disease in dogs relies primarily on serology; the most commonly used test in practice is the C6 antibody ELISA (included in the SNAP 4Dx Plus, SNAP 4Dx, and Accuplex 4 in-clinic combination tests), which detects antibodies against the C6 peptide from Borrelia’s OspC-related lipoprotein; a positive C6 ELISA indicates exposure to Borrelia but does not by itself distinguish between infection requiring treatment and seropositive-but-asymptomatic dogs (a large proportion of dogs in endemic areas seroconvert without developing clinical signs); the Quantitative C6 antibody test (QC6, run by IDEXX Laboratories on the same serum sample that was positive on C6 ELISA) provides a numerical antibody titer and is used to guide treatment decisions: QC6 values above 30 units/mL in a symptomatic dog support treatment; QC6 is also used to monitor treatment response (a significant decrease at 6 months post-treatment indicates successful bacterial clearance).
- Treatment of symptomatic Lyme disease in dogs uses doxycycline (a tetracycline antibiotic) at 10 mg/kg orally once daily (or 5 mg/kg twice daily) for 28 to 30 days; dogs typically begin to show clinical improvement within 24 to 48 hours of starting doxycycline, which is itself diagnostically informative; the full course must be completed even if signs resolve quickly, as residual Borrelia can persist in sequestered tissue sites including joints and lymph nodes; amoxicillin (20 mg/kg orally three times daily for 28 days) is an alternative in young dogs or in cases where doxycycline causes gastrointestinal intolerance; unlike in humans, prolonged antibiotic courses (more than 30 days) are not supported by evidence in dogs and are not recommended.
- Lyme disease prevention in dogs involves two complementary strategies: year-round tick prevention with a veterinarian-approved acaricide product (isoxazoline class: afoxolaner/NexGard, sarolaner/Simparica, fluralaner/Bravecto, lotilaner/Credelio; or other classes: amitraz collar/Seresto, permethrin spot-ons) combined with Lyme vaccination for dogs at risk due to geographic location or lifestyle; currently available canine Lyme vaccines include OspA-based bacterin vaccines (Merial/Boehringer Ingelheim Recombitek Lyme, Zoetis Vanguard crLyme), which prime the dog’s immune system to kill Borrelia within the tick’s midgut before the spirochete can be transmitted, and multivalent OspC vaccines that provide broader cross-strain protection; the Lyme vaccine series requires a 2-injection initial series (3 to 4 weeks apart) followed by annual boosters; vaccination is most beneficial in dogs in or traveling to endemic areas (northeastern and upper midwestern United States, northern California).
The Labrador Retriever had been hiking with her owner in Connecticut every weekend that summer. By early September she was limping on her left front leg; two days later the limping had shifted to her right rear. Her owner assumed she had sprained something on the trails. By the third week of September she was running a fever of 104.2 degrees, refusing to eat, and pressing herself into her bed. At the veterinary clinic, a SNAP 4Dx Plus test returned a positive result for Borrelia burgdorferi C6 antibody. A urine dipstick showed 3-plus protein. The veterinarian explained that the proteinuria warranted immediate investigation for Lyme nephropathy, ran a urine protein-to-creatinine ratio and a full chemistry panel, and started doxycycline the same day. The UPC came back at 4.8 (normal is below 0.5). The dog was treated aggressively; her QC6 dropped significantly at the 6-month recheck, but she carried persistent low-grade proteinuria for over a year, underscoring why early detection and prevention matter as much as treatment in Lyme-endemic areas.
The Pathogen and the Tick Vector
Borrelia burgdorferi is a motile, helically shaped (spirochete) gram-negative bacterium belonging to the family Spirochaetaceae. It is an obligate host-associated pathogen that does not survive for long periods outside a host. Borrelia’s genome is unusual in that it consists of a small linear chromosome plus numerous linear and circular plasmids, many of which encode the outer surface proteins (OspA, OspB, OspC, OspE) that the organism uses to evade host immune responses and adapt to different host environments.
The transmission cycle of B. burgdorferi is maintained in nature through a two-host tick cycle:
- Reservoir hosts (small mammals): White-footed mice (Peromyscus leucopus) are the primary reservoir hosts in the northeastern United States; they maintain Borrelia infection without becoming ill and infect naive larval ticks when those ticks take a blood meal; other rodents, shrews, and some bird species also serve as reservoir hosts
- Tick vector: Ixodes scapularis (black-legged tick, deer tick) in the eastern and midwestern United States; Ixodes pacificus (western black-legged tick) in California and the Pacific Northwest; Ixodes ricinus in Europe; these ticks have a two-year, three-stage life cycle (larva, nymph, adult); nymphs are responsible for the majority of human and animal infections because they are small (poppy-seed-sized), difficult to detect, and feed in spring and summer when human and pet outdoor activity is highest; adult ticks are more visible and feed primarily in fall and early winter
- Accidental hosts: Humans, dogs, horses, and other mammals are dead-end hosts that do not sustain the transmission cycle but can develop disease
Tick attachment duration is critical for Borrelia transmission: the spirochete resides primarily in the tick’s midgut in an OspA-expressing dormant state; after the tick attaches and begins feeding, rising host body temperature and blood meal signals trigger Borrelia to upregulate OspC expression and migrate from the midgut to the tick’s salivary glands, a process requiring a minimum of approximately 36 to 48 hours; transmission via saliva into the host then occurs; because this migration takes time, ticks removed within 36 hours of attachment are very unlikely to transmit Borrelia, making prompt tick removal one of the most effective preventive measures available.
Geographic Distribution and Seasonality
| Region | Primary Vector | Risk Level | Peak Season |
|---|---|---|---|
| Northeastern US (Maine, Connecticut, New York, New Jersey, Pennsylvania, Massachusetts, Vermont, New Hampshire, Rhode Island, Delaware, Maryland) | Ixodes scapularis | Very high; highest seroprevalence rates nationally, up to 70-80% in some hyperendemic areas | Year-round with peaks in May to July (nymphs) and October to December (adults) |
| Upper Midwestern US (Minnesota, Wisconsin, Michigan, Iowa) | Ixodes scapularis | High and expanding; dog seroprevalence increasing annually | May to August (nymphs); October to November (adults) |
| Pacific Coast (Northern California, Oregon, Washington) | Ixodes pacificus | Moderate; I. pacificus has lower reservoir host usage than I. scapularis | Spring and fall |
| Southern US, central plains | Ixodes scapularis present but low Borrelia prevalence | Low; I. scapularis present but fewer white-footed mice as reservoir hosts | Not a primary risk zone but cases reported in dogs with travel history |
| Europe (UK, Germany, France, Scandinavia, central Europe) | Ixodes ricinus | Variable; moderate to high in forested and rural areas; Borrelia garinii and B. afzelii genospecies predominate | Spring through fall |
Clinical Signs of Lyme Disease in Dogs
Typical Presentation (Lyme Arthritis)
Only approximately 5 to 10 percent of dogs exposed to Borrelia (as evidenced by seroconversion) develop clinical signs of Lyme disease; the majority of infected dogs remain asymptomatic seropositive carriers. When clinical signs do develop, they typically appear 2 to 5 months after tick exposure. The classic presentation of Lyme arthritis in dogs includes:
- Shifting-leg lameness: acute lameness affecting one limb, which may shift to a different limb over hours to days; the shifting nature reflects polyarthritis (inflammation in multiple joints) rather than single-joint pathology and is highly suggestive of Lyme disease in an endemic area
- Fever: body temperature typically 103 to 105 degrees Fahrenheit (normal is 99.5 to 102.5); dogs may feel warm to the touch on the ears and paw pads
- Peripheral lymphadenopathy: swelling of lymph nodes near affected joints, particularly prescapular, axillary, and popliteal lymph nodes
- Lethargy and anorexia: dogs are often significantly subdued and refuse food during acute episodes; owners frequently report the dog is “just not right”
- Joint swelling: affected joints (particularly the carpus/wrist and stifle/knee) may feel mildly swollen and warm; dogs resist manipulation of affected joints
Importantly, dogs with Lyme disease do not develop erythema migrans (the expanding bull’s-eye rash), cutaneous neurological signs, facial palsy, meningitis, or cardiac conduction abnormalities (heart block) that are well-documented complications in humans; Lyme carditis and Lyme neuroborreliosis are extremely rare in dogs compared with humans.
Lyme Nephropathy
Lyme nephropathy (Lyme-associated protein-losing nephropathy) is the most serious and life-threatening complication of Borrelia infection in dogs. The pathomechanism involves deposition of Borrelia-antigen and anti-Borrelia antibody immune complexes in the glomerular basement membrane, triggering a type III hypersensitivity reaction (immune complex-mediated inflammation), complement activation, recruitment of inflammatory cells, and progressive destruction of glomerular filtration units. This results in a membranoproliferative or membranous glomerulonephritis pattern on renal biopsy.
Clinical signs of Lyme nephropathy include:
- Proteinuria (often severe, UPC above 2.0 and frequently much higher): the earliest and most important screening finding
- Progressive azotemia: elevated blood urea nitrogen (BUN) and serum creatinine as glomerular filtration rate declines
- Hypoalbuminemia: serum albumin below 2.5 g/dL due to protein loss in urine; causes reduced oncotic pressure
- Peripheral pitting edema, ascites, or pleural effusion resulting from hypoalbuminemia
- Hypertension (systolic blood pressure above 150 to 160 mmHg) due to renin-angiotensin-aldosterone system activation from reduced renal perfusion
- Polydipsia and polyuria (PU/PD) as renal concentrating ability declines
- Anorexia, weight loss, vomiting as uremia develops in advanced cases
Lyme nephropathy carries a grave prognosis: many affected dogs do not survive longer than a few weeks to months after diagnosis, despite aggressive treatment. Breed predisposition is strong for Labrador Retrievers and Golden Retrievers; why these breeds develop nephropathy while others exposed to the same Borrelia strains do not remains incompletely understood but is thought to involve breed-specific immune response genetics.
Diagnosis
In-Clinic Serological Tests
| Test | What It Detects | Timing | Notes |
|---|---|---|---|
| SNAP 4Dx Plus (IDEXX) / Accuplex 4 (Antech) | C6 antibody against Borrelia burgdorferi; also tests for heartworm antigen, Ehrlichia canis/ewingii antibodies, Anaplasma phagocytophilum/platys antibodies | Antibodies typically detectable 3 to 5 weeks after tick exposure; persist for months to years | Most commonly used screening test in US practices; detects exposure/infection but not active disease; positive result in a symptomatic dog warrants QC6 testing and full diagnostic workup |
| C6 ELISA positive (quantitative C6 = QC6, run at IDEXX) | Quantitative measurement of anti-C6 antibody titer in units/mL | Run on the same serum sample that was positive on SNAP 4Dx | Values above 30 units/mL in a symptomatic dog generally support treatment; used for treatment monitoring (decrease of at least 50% at 6 months post-treatment is the treatment success criterion); values do not correlate with disease severity |
| Western blot (immunoblot) | Confirms presence of antibodies against multiple Borrelia-specific proteins (C6, OspA, OspC, flagellin) | Confirmatory test when C6 ELISA results are ambiguous | More specific than C6 ELISA; used to distinguish true positive from false positive results; not needed routinely when SNAP 4Dx Plus is positive and clinical signs are consistent |
Complete Diagnostic Workup for Lyme-Positive Dogs
A positive Borrelia C6 antibody result in any dog should prompt a complete assessment that goes beyond the serology alone:
- Urinalysis with urine sediment: look for proteinuria (dipstick 2-plus or greater), cylindruria (casts in sediment indicating renal tubular damage), and hematuria; proteinuria in a Lyme-positive dog is a red flag for Lyme nephropathy
- Urine protein-to-creatinine ratio (UPC): quantifies proteinuria precisely; normal is below 0.5 in dogs; UPC above 0.5 in a Lyme-positive dog warrants renal monitoring and specialist consultation; UPC above 2.0 suggests significant glomerular disease
- Serum chemistry panel: assess BUN, creatinine, albumin, total protein, electrolytes, and phosphorus to evaluate renal function and hypoalbuminemia
- Complete blood count: may show mild anemia, thrombocytopenia (low platelets), or neutrophilia in active Lyme disease; mild thrombocytopenia is common with tick-borne co-infections (Anaplasma, Ehrlichia) and may be detected on the same SNAP 4Dx Plus test
- Quantitative C6 (QC6) antibody: guides treatment decision and provides a baseline for monitoring treatment response
- Blood pressure measurement: systolic blood pressure measurement in Lyme-positive dogs with proteinuria; hypertension worsens renal damage and requires antihypertensive treatment (amlodipine, enalapril/benazepril)
Culture and PCR
Culture of Borrelia from blood, urine, or synovial fluid is technically possible but very insensitive and impractical in clinical settings; it requires specialized BSL-2 laboratory conditions and takes 6 to 8 weeks. PCR for Borrelia DNA from blood, urine, or joint fluid is more sensitive but still inferior to serology for diagnosing active infection; false negatives are common because spirochetemia is low and transient in dogs; PCR is occasionally useful for confirming active infection in seronegative dogs with highly suspicious clinical signs early in the course of infection (before seroconversion).
Treatment of Lyme Disease in Dogs
Antibiotic Treatment
| Drug | Dose | Duration | Notes |
|---|---|---|---|
| Doxycycline (first choice) | 10 mg/kg orally once daily OR 5 mg/kg orally twice daily | 28 to 30 days | Most commonly used and best-supported antibiotic for canine Lyme disease; dogs typically improve dramatically within 24 to 48 hours of starting treatment; administer with food to reduce gastrointestinal side effects (vomiting, esophageal stricture risk); avoid dairy products and antacids within 2 hours of dosing as calcium chelates doxycycline; avoid sun exposure as photosensitization can occur; do not use in young dogs whose permanent teeth are developing (younger than 6 months in small breeds, younger than 12 months in large breeds) due to dental enamel hypoplasia |
| Amoxicillin (alternative) | 20 mg/kg orally three times daily | 28 days | Alternative when doxycycline is contraindicated (very young dogs, esophageal disease); less convenient three-times-daily dosing; good tissue penetration; beta-lactam that inhibits Borrelia cell wall synthesis |
| Azithromycin | 25 mg/kg orally once daily | 10 to 14 days | Used occasionally as an alternative but less well-studied in canine Lyme disease than doxycycline; generally not a first-line choice in dogs |
Asymptomatic Seropositive Dogs
The decision to treat a Lyme-seropositive dog that has no clinical signs is controversial and not universally standardized. The ACVIM (American College of Veterinary Internal Medicine) consensus statement suggests considering treatment in asymptomatic dogs with QC6 above 30 units/mL given the presence of active infection and the low risk of a 30-day doxycycline course; other clinicians reserve treatment for symptomatic dogs only. At minimum, asymptomatic Lyme-positive dogs should receive: urinalysis with UPC (to screen for subclinical Lyme nephropathy), a chemistry panel, QC6 testing, and recheck urinalysis in 6 months regardless of treatment decision. Any asymptomatic dog in high-risk breeds (Labrador Retriever, Golden Retriever) with a positive C6 ELISA and any degree of proteinuria should be treated and monitored closely for nephropathy progression.
Lyme Nephropathy Treatment
Lyme nephropathy requires aggressive management beyond antibiotics alone. Treatment components include:
- Doxycycline (or amoxicillin) to eliminate the Borrelia antigenic stimulus driving immune complex deposition
- ACE inhibitor or ARB (benazepril, enalapril, or telmisartan) to reduce glomerular hypertension, decrease proteinuria, and slow progression of glomerular damage; these are the most important renoprotective medications in Lyme nephropathy
- Antihypertensive therapy (amlodipine) if systolic blood pressure exceeds 160 mmHg
- Dietary protein restriction (renal diet) once BUN and creatinine are elevated
- Low-molecular-weight heparin for thromboprophylaxis in dogs with severe hypoalbuminemia (serum albumin below 2.0 g/dL) due to the hypercoagulable state associated with protein-losing nephropathy
- Omega-3 fatty acid supplementation for anti-inflammatory renal effects
- Fluid therapy in uremic dogs; peritoneal dialysis or hemodialysis at specialty centers for severe acute kidney injury
Prevention
Tick Prevention Products
| Product Class | Examples | Route | Duration | Notes |
|---|---|---|---|---|
| Isoxazolines (most effective class) | Afoxolaner (NexGard), sarolaner (Simparica, Simparica Trio), fluralaner (Bravecto), lotilaner (Credelio) | Oral chew | Monthly (NexGard, Credelio) or every 3 months (Bravecto) or monthly (Simparica) | Systemic insecticide/acaricide; kills ticks after attachment but typically before 36 to 48 hours (before Borrelia transmission); very high efficacy against Ixodes; FDA approved for dogs; require prescription; do not use in dogs with a history of seizures without veterinary consultation |
| Amitraz collar | Seresto (imidacloprid/flumethrin) | Topical collar | 8 months | Repels and kills ticks; flumethrin repels Ixodes ticks, reducing attachment rate; good efficacy; OTC availability (prescription required in some regions); do not use with amitraz-containing dips concurrently; keep away from children and cats |
| Permethrin spot-on | K9 Advantix II (imidacloprid/permethrin) | Topical spot-on | Monthly | Repels and kills ticks; permethrin is highly effective against Ixodes; NEVER use on or near cats (permethrin is acutely toxic to cats); dogs in multi-cat households should be kept away from cats until the product dries completely |
Lyme Vaccination
Lyme vaccination is recommended by the American Animal Hospital Association (AAHA) canine vaccination guidelines for dogs at risk due to geographic location or lifestyle (hunting, hiking, rural living in endemic areas). Available vaccines in the United States:
- OspA bacterin vaccines (Recombitek Lyme by Boehringer Ingelheim, Vanguard crLyme by Zoetis): contain killed whole Borrelia or recombinant OspA antigen; OspA is expressed on Borrelia within the tick’s midgut; when a vaccinated dog is bitten by an infected tick, anti-OspA antibodies taken up in the tick’s blood meal kill the spirochetes within the tick’s midgut before they can migrate to the salivary glands and be transmitted; this is called “pre-feeding killing” and is a unique mechanism for a vaccine; these vaccines require a 2-injection initial series 3 to 4 weeks apart followed by annual boosters before tick season
- Outer surface protein C (OspC) adjuvanted multivalent vaccines: newer vaccine formulations incorporating multiple Borrelia strains and OspC epitopes for broader cross-strain protection; these prime the dog’s immune system to neutralize Borrelia after transmission but before systemic dissemination
Vaccination does not replace tick prevention; both strategies used together provide the best protection. The Lyme vaccine does not protect against other tick-borne diseases (Anaplasma, Ehrlichia, Rocky Mountain spotted fever), making year-round tick prevention products essential regardless of vaccination status.
Tick Checks and Manual Removal
Daily tick checks remain a critical prevention layer. Run fingers through the coat in the direction from skin outward, checking high-risk attachment sites: between the toes, under the collar and around the neck, in the groin and axillary (armpit) region, around the tail base, and inside the ear pinnae. Use fine-tipped tweezers or a tick removal tool to grasp the tick as close to the skin surface as possible and pull upward with steady, even pressure; do not twist, jerk, or squeeze the tick’s body; do not apply petroleum jelly, nail polish, or a hot match to the tick (these methods can cause the tick to regurgitate into the wound). After removal, disinfect the bite site with rubbing alcohol. Ticks can be submitted to university extension programs or commercial tick identification services for species identification and pathogen testing.
US Cost Overview for Lyme Disease
| Service | Typical US Cost |
|---|---|
| Annual heartworm/tick panel (SNAP 4Dx Plus) | $45 to $90 (included in most annual wellness visits) |
| Quantitative C6 (QC6) test at reference laboratory | $60 to $120 |
| Complete blood count and chemistry panel | $120 to $250 |
| Urinalysis and urine protein-to-creatinine ratio | $80 to $180 |
| Blood pressure measurement | $30 to $75 |
| Doxycycline 30-day course | $30 to $80 (generic) |
| Veterinary examination (diagnosis visit) | $60 to $180 |
| Annual Lyme vaccination (2-dose initial series) | $50 to $120 for both doses |
| Monthly isoxazoline tick prevention (annual cost) | $120 to $300 depending on product and dog size |
| Seresto collar (8-month protection) | $50 to $75 |
| Lyme nephropathy hospitalization and treatment | $2,000 to $8,000 or more depending on severity and duration |
Age-Specific Considerations
Puppies (Under 6 Months)
- Puppies can be vaccinated against Lyme disease starting at 8 to 9 weeks of age with the first dose of the 2-injection initial series; the second dose is given 3 to 4 weeks later; first booster at 1 year; a puppy that receives its initial series and then is exposed to Borrelia-carrying ticks before immunity is fully established (within the first 2 to 3 weeks after completing the initial series) is still at some risk, making tick prevention products critical during this window
- Doxycycline is contraindicated in puppies whose permanent teeth are still developing due to the risk of permanent yellow-brown dental enamel hypoplasia (doxycycline chelates calcium and incorporates into developing enamel and bone); for puppies under 6 months (small breeds) or under 12 months (large breeds), amoxicillin is the treatment of choice if Lyme disease is diagnosed; this is an important age-based distinction that practitioners must recognize
- Puppies living in or traveling to Lyme-endemic areas should begin tick prevention as early as the product label allows; isoxazoline products (NexGard, Credelio) are labeled for use starting at 8 weeks; Bravecto is labeled from 8 weeks; Simparica from 8 weeks; Seresto collar from 7 weeks; always verify the minimum age on the specific product label before use in young puppies
Adult Dogs (1 to 8 Years)
- Adult dogs in Lyme-endemic areas should receive an annual SNAP 4Dx Plus (or equivalent combination heartworm/tick panel) at every wellness visit; this annual screening catches Lyme seroconversion before clinical signs develop and identifies asymptomatic seropositive dogs who need UPC screening and QC6 monitoring; the annual tick panel has become the standard of care in endemic regions, equivalent to annual heartworm testing in heartworm-endemic regions, and represents one of the most cost-effective preventive measures in veterinary medicine
- Adult dogs who test positive on C6 ELISA for the first time and who are symptomatic should begin doxycycline the same day as the diagnosis if renal and hepatic values are normal (doxycycline is hepatically metabolized; a chemistry panel is warranted before starting treatment but should not significantly delay treatment in a clinically ill dog); the characteristic rapid clinical improvement within 24 to 48 hours of starting doxycycline is diagnostically satisfying and practically important, as it helps distinguish Lyme arthritis from immune-mediated polyarthritis, joint sepsis, or orthopedic disease
- Sexually intact or recently spayed or neutered adult dogs in high-risk breeds (Labrador Retrievers, Golden Retrievers) who live in endemic areas should be counseled specifically about the risk of Lyme nephropathy; annual UPC screening in seropositive individuals of these breeds is recommended by the ACVIM glomerulonephritis consensus statement; even a mildly elevated UPC (0.5 to 2.0) in a Lyme-positive Labrador or Golden Retriever should be taken seriously and monitored at 1 to 3 month intervals
Senior Dogs (9 Years and Older)
- Senior dogs have natural age-related decline in glomerular filtration rate (GFR) and renal reserve; this makes them more vulnerable to the additive renal injury of Lyme nephropathy if they develop it; a senior seropositive dog with any degree of proteinuria or azotemia requires urgent evaluation to determine whether the kidney disease reflects Lyme-associated glomerulonephritis, age-related chronic kidney disease (CKD) without Lyme involvement, or a combination; the International Renal Interest Society (IRIS) staging system for CKD and the IRIS staging of CKD with proteinuria should both be applied; treatment decisions for Lyme nephropathy in a senior CKD dog require careful individualization with a veterinary internal medicine specialist
- Senior dogs traveling from non-endemic to endemic regions (a common scenario for retirees or seasonal residents moving between the South and the Northeast) may lack Lyme immunity and face their first tick-borne disease risk at an age when their immune and renal reserves are already reduced; these dogs benefit particularly from Lyme vaccination before travel and year-round isoxazoline tick prevention; their owners should be counseled about the higher stakes of delayed diagnosis in an older dog with less physiological reserve
- Doxycycline is generally well tolerated in senior dogs, but the prescribing veterinarian should review the chemistry panel before a 30-day course in a senior dog with known hepatic or renal compromise; doxycycline is hepatically metabolized and excreted in bile (partially) and urine (partially); dose adjustment is not routinely necessary in mild to moderate chronic kidney disease but the treating veterinarian should monitor for accumulation signs (GI upset, inappetence) and consider splitting the dose to twice daily if once-daily dosing causes significant nausea
Myths and Facts About Lyme Disease in Dogs
Dogs with Lyme disease get the bull’s-eye rash, just like humans.
Erythema migrans (the expanding bull’s-eye rash) is a hallmark of early Lyme disease in humans but does not occur in dogs. Dogs have a thick coat that conceals the skin, and also do not develop the same cutaneous inflammatory response to Borrelia as humans do. In dogs, Lyme disease presents as lameness, fever, lethargy, and lymphadenopathy, not as a skin rash. The absence of a bull’s-eye rash in dogs is a source of frequent confusion for owners who are familiar with Lyme disease from their own healthcare experience.
A tick must be attached for days before it can transmit Lyme disease to my dog.
While it is true that Borrelia transmission requires a minimum attachment time of approximately 36 to 48 hours (reflecting the time needed for spirochetes to migrate from the tick’s midgut to its salivary glands), this does not mean days of attachment are needed. A tick attached for just over 36 to 48 hours has already passed the transmission threshold. This is why the standard recommendation is to check your dog for ticks after every outdoor exposure and remove any attached ticks within 24 hours; waiting until the tick has been visible for “a couple of days” is too late for reliable prevention.
If my dog tested positive for Lyme disease, they will always test positive and always need treatment.
A positive C6 ELISA indicates exposure to Borrelia and development of an antibody response, but does not automatically mean the dog needs treatment. In endemic areas, a large proportion of dogs seroconvert without ever developing clinical signs. The decision to treat is based on clinical signs, QC6 titer level, and urinalysis results, not on seropositivity alone. After a 30-day course of doxycycline in a treated dog, the QC6 titer typically decreases significantly by 6 months but may not reach zero; a persistently positive C6 ELISA does not mean re-treatment is needed unless clinical signs recur or the QC6 titer rises significantly.
Red Flags: Signs That Require Urgent Veterinary Care
- Swollen limbs or face, pitting edema (indentation remains after pressing the skin), or a visibly distended abdomen in a dog that tested Lyme-positive: these are signs of hypoalbuminemia from protein-losing nephropathy and require same-day evaluation
- Persistent or severe lethargy lasting more than 48 hours, inability to stand, or near-collapse in a dog that has been in tick-endemic areas: these warrant immediate veterinary evaluation; Lyme disease can occasionally produce acute severe illness in dogs with a heavy Borrelia burden, and other tick-borne co-infections (Anaplasma, Ehrlichia) can produce similar presentations with thrombocytopenia and severe systemic illness
- Acute-onset severe lameness with fever in a dog that has not been on tick prevention: this is the textbook presentation of Lyme arthritis and warrants same-day veterinary evaluation, a SNAP 4Dx Plus test, and a urinalysis; do not assume this is a musculoskeletal sprain without ruling out tick-borne disease in an endemic area
- Excessive thirst and urination (PU/PD) combined with weight loss in a Lyme-positive dog: this may indicate progressive renal compromise from Lyme nephropathy and requires a chemistry panel and UPC as soon as possible
- Any Lyme-positive dog showing vomiting, inappetence, and lethargy: these non-specific signs can represent Lyme arthritis flares, uremic signs from advancing nephropathy, or co-infection with Ehrlichia or Anaplasma; same-day veterinary evaluation is warranted
- A Lyme-positive dog showing neurological signs (weakness, stumbling, behavioral changes): while Lyme neuroborreliosis is rare in dogs compared with humans, severe Borrelia infection or renal encephalopathy from advanced Lyme nephropathy can produce neurological signs; these require urgent evaluation
Frequently Asked Questions About Lyme Disease in Dogs
What are the symptoms of Lyme disease in dogs?
The classic signs are shifting-leg lameness (moving from one limb to another over days), fever of 103 to 105 degrees Fahrenheit, swollen lymph nodes, lethargy, and reduced appetite. Dogs do not develop the bull’s-eye rash seen in humans. Signs typically appear 2 to 5 months after tick exposure. Only about 5 to 10 percent of infected dogs develop clinical signs; the rest remain asymptomatic despite seroconverting.
How is Lyme disease diagnosed in dogs?
The standard screening test is the C6 antibody ELISA, included in the SNAP 4Dx Plus in-clinic combination panel. A positive result triggers a Quantitative C6 (QC6) test at a reference laboratory to measure titer level and guide treatment. Every Lyme-positive dog should also receive a urinalysis with protein-to-creatinine ratio (UPC) and a chemistry panel to screen for Lyme nephropathy. Western blot testing is reserved for ambiguous cases.
How do you treat Lyme disease in dogs?
Treatment is doxycycline 10 mg/kg orally once daily (or 5 mg/kg twice daily) for 28 to 30 days. Dogs typically improve dramatically within 24 to 48 hours of starting treatment. In puppies under 6 months, amoxicillin 20 mg/kg three times daily for 28 days is used instead (doxycycline is contraindicated due to effects on developing teeth). Lyme nephropathy requires additional management with ACE inhibitors, antihypertensives, and dietary modification.
Do dogs need the Lyme vaccine?
The Lyme vaccine is recommended for dogs at risk due to geographic location (living in or traveling to endemic areas in the Northeast, upper Midwest, or Pacific Coast) or lifestyle (hunting, hiking, rural living). It is given as a 2-injection initial series 3 to 4 weeks apart with annual boosters. Vaccination does not replace tick prevention; both strategies together offer the best protection. The vaccine is not considered necessary for dogs with no exposure risk in non-endemic areas.
What is Lyme nephropathy in dogs?
Lyme nephropathy is a severe immune-mediated glomerulonephritis (kidney damage) caused by deposition of Borrelia antigen-antibody complexes in the kidney’s filtration units. It produces proteinuria, progressive kidney failure, hypoalbuminemia, and sometimes edema or ascites. It carries a grave prognosis. Labrador Retrievers and Golden Retrievers are at highest risk. Any Lyme-positive dog should be screened with a urine protein-to-creatinine ratio (UPC) to detect early nephropathy.
Can Lyme disease in dogs spread to humans?
Dogs cannot directly transmit Lyme disease to humans; there is no dog-to-human transmission pathway. However, a dog that has been in tick-infested areas can carry infected ticks into the home on its coat. These ticks may detach from the dog and attach to human family members before feeding. The dog therefore serves as a “sentinel” and a “tick transport host” rather than a direct source of Borrelia. Year-round tick prevention on the dog protects not just the dog but also reduces tick burden introduced into the household.
How long do I need to protect my dog against ticks?
Year-round tick prevention is recommended in endemic areas, not just spring through fall. Adult Ixodes scapularis ticks are active in late fall and winter whenever temperatures rise above 35 degrees Fahrenheit (approximately 2 degrees Celsius), meaning brief winter warm spells can produce tick activity in November through March in the northeastern United States. Monthly isoxazoline products given year-round eliminate this seasonal gap and are the recommended standard for dogs in endemic regions.
For more guides on keeping your dog healthy, browse all our Dog Health articles.
Explore Dog Health Articles